Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains

被引:105
作者
Tian, Minjie [1 ]
Zhu, Donglin [1 ]
Xie, Wei [1 ]
Shi, Jingping [1 ]
机构
[1] Nanjing Med Univ, Dept Neurol, Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China
关键词
Angiotensin II; Glycogen synthase kinase 3 beta; Tau; Alzheimer disease; CEREBRAL-BLOOD-FLOW; COGNITIVE IMPAIRMENT; DISEASE; HYPOTHESIS; KINASES; BENCH;
D O I
10.1016/j.febslet.2012.09.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Growing evidence suggests that Alzheimer disease (AD) origins in vascular lesions. As the crucial mediator of vascular pathology, angiotensin II-induced significant amyloid production in our laboratory, although amyloid neurotoxicity depended on phosphorylated tau (p-tau) in recent studies. In the present study, p-tau levels were significantly elevated by central angiotensin II via glycogen synthase kinase 3 beta (GSK 3 beta) and other tau kinases. Moreover, angiotensin II-induced cognitive impairment and tau phosphorylation was attenuated by losartan and a GSK 3 beta inhibitor. These findings implicate Ang II as a crucial mediator of AD pathology and a link between cardiovascular events and AD. (c) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3737 / 3745
页数:9
相关论文
共 38 条
[1]
NEUROFIBRILLARY TANGLES BUT NOT SENILE PLAQUES PARALLEL DURATION AND SEVERITY OF ALZHEIMERS-DISEASE [J].
ARRIAGADA, PV ;
GROWDON, JH ;
HEDLEYWHYTE, ET ;
HYMAN, BT .
NEUROLOGY, 1992, 42 (03) :631-639
[2]
Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway [J].
Chen, Kun-Lin ;
Yuan, Rey-Yue ;
Hu, Chaur-Jong ;
Hsu, Chung Y. .
NEUROBIOLOGY OF DISEASE, 2010, 40 (02) :378-385
[3]
Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease [J].
Danielyan, Lusine ;
Klein, Roman ;
Hanson, Leah R. ;
Buadze, Marine ;
Schwab, Matthias ;
Gleiter, Christoph H. ;
Frey, William H., II .
REJUVENATION RESEARCH, 2010, 13 (2-3) :195-201
[4]
Vascular risk factor detection and control may prevent Alzheimer's disease [J].
de la Torre, Jack C. .
AGEING RESEARCH REVIEWS, 2010, 9 (03) :218-225
[5]
The Vascular Hypothesis of Alzheimer's Disease: Bench to Bedside and Beyond [J].
de la Torre, Jack C. .
NEURODEGENERATIVE DISEASES, 2010, 7 (1-3) :116-121
[6]
Desikan R.S., 2012, ARCH NEUROL, V287
[7]
Amyloid-β Associated Volume Loss Occurs Only in the Presence of Phospho-Tau [J].
Desikan, Rahul S. ;
McEvoy, Linda K. ;
Thompson, Wesley K. ;
Holland, Dominic ;
Roddey, J. Cooper ;
Blennow, Kaj ;
Aisen, Paul S. ;
Brewer, James B. ;
Hyman, Bradley T. ;
Dale, Anders M. .
ANNALS OF NEUROLOGY, 2011, 70 (04) :657-661
[8]
Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595
[9]
Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease [J].
Dong, Yi-Fei ;
Kataoka, Keiichiro ;
Tokutomi, Yoshiko ;
Nako, Hisato ;
Nakamura, Taishi ;
Toyama, Kensuke ;
Sueta, Daisuke ;
Koibuchi, Nobutaka ;
Yamamoto, Eiichiro ;
Ogawa, Hisao ;
Kim-Mitsuyama, Shokei .
FASEB JOURNAL, 2011, 25 (09) :2911-2920
[10]
The role of GSK3 in Alzheimer disease [J].
Hernandez, Felix ;
Gomez de Barreda, Elena ;
Fuster-Matanzo, Almudena ;
Goni-Oliver, Paloma ;
Lucas, Jose J. ;
Avila, Jesus .
BRAIN RESEARCH BULLETIN, 2009, 80 (4-5) :248-250